RUVBL2 and cancer: Conceptually, an increase in Ruvbl2lik activity that augments cardiomyocyte proliferation is consistent with the established oncogenic role of Ruvbl2 in a variety of cancers where it is significantly overexpressed (Mao and Houry, 2017).